"The newly empowered Democrats' vow to cut healthcare costs might spell bad news for the brand-name pharmaceutical industry, but could provide new momentum for generic drug rivals, the Wall Street Journal reported on its Web site on Tuesday. "
.How could more competition be bad? Unless of course Dems want to protect generic companies from competition in the process,.,,If the GOP is smart, they will respond with measures to accelerate and encourage development of new drugs too -- as well as protect authorized generics -- since new drugs are the source of generic profits in the final analysis and authorized generics ultimately promote more price competition!
.How could more competition be bad? Unless of course Dems want to protect generic companies from competition in the process,.,,If the GOP is smart, they will respond with measures to accelerate and encourage development of new drugs too -- as well as protect authorized generics -- since new drugs are the source of generic profits in the final analysis and authorized generics ultimately promote more price competition!
